Brind.
  1. XOMA Royalty operates within the biomedical industry, and its stock performance was compared to the market index on August 13, 2025.

Zacks Investment Research provided stock analysis and rankings for XOMA Royalty Corporation, a company in the biomedical industry.

1 report, 0 independent Updated Jun 24
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.

What happened

SpeculativeNo independent reporting found

Zacks Investment Research provided stock analysis and rankings for XOMA Royalty Corporation, a company in the biomedical industry.

Who's involved

What this event is mainly about
Compugen Ltd.

Keep exploring

Part of

XOMA Royalty operates within the biomedical industry, and its stock performance was compared to the market index on August 13, 2025. All 1 developments

The entities involved

  • Compugen Ltd.

    publicly traded Israeli drug discovery company

    Nothing else this week.

Coverage

Newest first; wire copies grouped
  • Unknown outlet